cyclin E2 Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin E2 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin E2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin E2 is a crucial regulator of the cell cycle, specifically involved in the transition from the G1 phase to the S phase, where DNA replication occurs. Its dysregulation has been implicated in various cancers, making cyclin E2 an important target for understanding tumorigenesis and developing therapeutic strategies. By studying cyclin E2, researchers can gain insights into cell proliferation and the mechanisms underlying cancer progression. Cyclin E2 monoclonal antibodies enable precise detection and analysis of protein expression patterns in diverse experimental settings. Understanding cyclin E2's role in cell cycle control can lead to new therapeutic approaches for cancer treatment. The exceptional quality and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cell cycle regulation and cancer biology.